Full Text View
Tabular View
No Study Results Posted
Related Studies
Can Blood Glucose Levels During the Perioperative Period Identify a Population at Risk for Hyperglycemia?
This study is currently recruiting participants.
Verified by University of Medicine and Dentistry New Jersey, April 2009
First Received: April 30, 2007   Last Updated: April 1, 2009   History of Changes
Sponsored by: University of Medicine and Dentistry New Jersey
Information provided by: University of Medicine and Dentistry New Jersey
ClinicalTrials.gov Identifier: NCT00468494
  Purpose

Surgery performed during general anesthesia induces a stress effect on the body. Our plan is to identify population at risk of hyperglycemia during perioperative period.


Condition
General Anesthesia
Hyperglycemia

MedlinePlus related topics: Anesthesia
U.S. FDA Resources
Study Type: Observational
Study Design: Prospective
Official Title: Can Blood Glucose Levels During the Perioperative Period Identify a Population at Risk for Hyperglycemia

Further study details as provided by University of Medicine and Dentistry New Jersey:

Biospecimen Retention:   None Retained

Biospecimen Description:

Estimated Enrollment: 300
Study Start Date: September 2006
Estimated Study Completion Date: October 2009
Estimated Primary Completion Date: October 2009 (Final data collection date for primary outcome measure)
Detailed Description:

This is a prospective study to define the relationship between time profile of glucose control before, during and after surgery with patient variables, surgical variables and anesthetic variables. Serum glucose levels will be measured preoperatively and then at 30 minute intervals during surgery. Pain score, pain medication and glucose levels will be measured in the post anesthesia recovery room.

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

non-diabetic adults undergoing surgery

Criteria

Inclusion Criteria:

  • Elective surgery
  • 18-80 years of age

Exclusion Criteria:

  • Known diabetics
  • Pregnant patients
  • Cardiac surgery patients
  • Liver transplant patients
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00468494

Contacts
Contact: Catherine Schoenberg, BSN 973 972-7477 shoenbce@umdnj.edu
Contact: Vasanti . Tilak, MD 973 972-5254 tilakva@umdnj.edu

Locations
United States, New Jersey
University of Medicine & Dentistry of New Jersey Recruiting
Newark, New Jersey, United States, 07107
Principal Investigator: Vasanti Tilak, MD            
Sponsors and Collaborators
University of Medicine and Dentistry New Jersey
Investigators
Principal Investigator: Vasanti Tilak, MD University of Medicine & Dentistry of New Jersey-NJMS
  More Information

No publications provided

Responsible Party: UMDNJ ( Vasanti Tilak, MD )
Study ID Numbers: 0120060208
Study First Received: April 30, 2007
Last Updated: April 1, 2009
ClinicalTrials.gov Identifier: NCT00468494     History of Changes
Health Authority: United States: Institutional Review Board

Keywords provided by University of Medicine and Dentistry New Jersey:
non diabetic
catabolic energy state

Study placed in the following topic categories:
Metabolic Diseases
Hyperglycemia
Glucose Metabolism Disorders
Metabolic Disorder

Additional relevant MeSH terms:
Metabolic Diseases
Hyperglycemia
Glucose Metabolism Disorders

ClinicalTrials.gov processed this record on May 06, 2009